1. Home
  2. WEST vs LCTX Comparison

WEST vs LCTX Comparison

Compare WEST & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westrock Coffee Company

WEST

Westrock Coffee Company

HOLD

Current Price

$4.33

Market Cap

379.6M

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

BUY

Current Price

$1.66

Market Cap

393.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
WEST
LCTX
Founded
2009
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
379.6M
393.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WEST
LCTX
Price
$4.33
$1.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$9.00
$4.25
AVG Volume (30 Days)
625.7K
2.4M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,078,457,000.00
$10,816,000.00
Revenue This Year
$40.23
N/A
Revenue Next Year
$8.80
$176.00
P/E Ratio
N/A
N/A
Revenue Growth
28.89
24.05
52 Week Low
$3.59
$0.37
52 Week High
$8.29
$2.09

Technical Indicators

Market Signals
Indicator
WEST
LCTX
Relative Strength Index (RSI) 48.54 44.23
Support Level $4.00 $1.66
Resistance Level $4.48 $1.76
Average True Range (ATR) 0.29 0.12
MACD 0.05 -0.02
Stochastic Oscillator 57.74 7.04

Price Performance

Historical Comparison
WEST
LCTX

About WEST Westrock Coffee Company

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: